Results 51 to 60 of about 7,598 (253)

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

open access: yesChemBioChem, Volume 27, Issue 1, January 2026.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh   +7 more
wiley   +1 more source

Diagnosis and management of osteoporosis in the older senior

open access: yesClinical Interventions in Aging, 2009
Sheryl F Vondracek, Sunny A LinneburDepartment of Clinical Pharmacy, School of Pharmacy C238-L15, University of Colorado Denver, Aurora, CO, USAAbstract: The older senior is at high risk for osteoporosis.
Sheryl F Vondracek, Sunny A Linnebur
doaj  

A pH‐Responsive Synthetic Receptor for Switchable Binding of Carbohydrates

open access: yesChemPlusChem, Volume 90, Issue 12, December 10, 2025.
A diaminocarbazole macrocyclic receptor, designed for disaccharide recognition in water, exhibits distinct binding properties under alkaline versus neutral pH conditions. Carbohydrates are selectively recognized under alkaline conditions, whereas release of the bound guest occurs at physiological pH, effectively behaving as a pH‐switchable carbohydrate
Francesco Milanesi   +4 more
wiley   +1 more source

Fractures in CKD Patients—Risk Analysis in RRT Lombardy Patients

open access: yesKidney and Dialysis, 2023
The increase in the number of patients with CKD starting dialysis treatment has become a major health problem in recent years. Osteoporosis is a typical feature of advanced age, which, in the dialysis population, is almost always accompanied by uremic ...
Ferruccio Conte   +5 more
doaj   +1 more source

Bisfosfonatos y Patología Oral I: aspectos generales y preventivos [PDF]

open access: yes, 2006
Los bisfosfonatos constituyen un grupo de fármacos capaces de modular el recambio óseo y disminuir su remodelado cuando existe una reabsorción excesiva.
Aguirre Urízar, José Manuel   +2 more
core  

Doping and band-gap engineering of an intrazeolite tungsten(VI) oxide supralattice [PDF]

open access: yes, 1991
New results are presented concerning the topotactic self-assembly, n-type doping and band-gap engineering of an intrazeolite tungsten(VI) oxide supralattice n(W03)-Na56Y, where 0 < η < 32, built-up of single size and shape (W03)2 dimers. In particular
Bein, Thomas   +6 more
core   +1 more source

Nuclear imaging and echocardiographic findings in hypertrophic cardiomyopathy with and without ATTR‐CM

open access: yesESC Heart Failure, Volume 12, Issue 6, Page 4349-4358, December 2025.
Abstract Aims Patients with transthyretin amyloid cardiomyopathy (ATTR‐CM) often experience delayed diagnosis, which may detrimentally impact clinical outcomes. This study aimed to assess the frequency of use of planar scintigraphy with and without single‐photon emission computed tomography (SPECT) in patients with hypertrophic cardiomyopathy (HCM ...
Pablo Garcia‐Pavia   +11 more
wiley   +1 more source

Preoperative Assessment of Medication-Related Osteonecrosis of the Jaw Using [18F]fluoride Positron Emission Tomography (PET)/CT and [18F]fluorodeoxyglucose PET/MRI in Correlation with Histomorphometry and Micro-CT—A Prospective Comparative Study

open access: yesDiagnostics
Objectives: The purpose of this study was to investigate the imaging characteristics of medication-related osteonecrosis of the jaw (MRONJ) using [18F]fluoride positron emission tomography/computed tomography (PET/CT) and [18F]fluorodeoxyglucose (FDG ...
Christian Philipp Reinert   +8 more
doaj   +1 more source

Defects and disorder in metal organic frameworks. [PDF]

open access: yes, 2016
The wide-ranging properties of metal organic frameworks (MOFs) rely in many cases on the presence of defects within their structures and the disorder that is inevitably associated with such defects.
Bennett, Thomas D   +3 more
core   +2 more sources

CTHRC1 promotes bone metastasis in prostate cancer

open access: yesInternational Journal of Cancer, Volume 157, Issue 11, Page 2399-2412, 1 December 2025.
What's New? The mechanisms driving bone metastasis in prostate cancer are still unclear, and predicting markers have not yet been identified. Based on the biological characterization of prostate cancer cell lines and integrated data analysis of clinical samples, the authors identified CTHRC1 as a candidate gene regulating prostate cancer bone ...
Yuichiro Sawada   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy